SHILPA MEDICARE LTD (SHILPAMED) financials

SHILPA MEDICARE LTD (SHILPAMED) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company’s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML’s wholly owned subsidiary Shilpa Therapeutics.[1]

Market Cap: ₹19,830Cr.
Current Price: ₹1,014
Stock P/E: 127
ROE: 3.88%
ROCE: 4.79%
Book Value: ₹139
Dividend Yield: 0.06%
52W High / Low: ₹1,096/260

In Jun 2026, SHILPA MEDICARE LTD (SHILPAMED) reported sales ₹189 Cr and net profit ₹65 Cr.

Annual TTM: sales ₹691 Cr, net profit ₹183 Cr.

Shareholding: Promoters 40.13% (Sep 2026), FIIs 12.11% (Sep 2026), DIIs 8.26% (Sep 2026), Public 39.49% (Sep 2026), No. of Shareholders 87,477% (Sep 2026).

SHILPAMED quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	130	125	126	92	135	166	201	189
Expenses	87	103	88	75	96	135	141	133
Operating Profit	43	22	38	17	39	31	60	56
OPM %	33%	18%	30%	18%	29%	19%	30%	30%
Other Income	20	16	-34	13	15	9	35	13
Interest	1	1	2	2	2	3	3	3
Depreciation	12	12	12	13	13	14	14	15
Profit before tax	50	25	-10	15	39	24	78	51
Tax %	40%	37%	-43%	-40%	21%	33%	9%	-27%
Net Profit	30	16	-6	21	31	16	71	65
EPS in Rs	1.53	0.80	-0.29	1.06	1.58	0.81	3.63	3.32
Raw PDF	—	—	—	—	—	—	—	—

SHILPAMED profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	806	257	357	248	310	476	596	691
Expenses	561	223	335	291	284	340	440	505
Operating Profit	245	34	22	-44	26	136	156	186
OPM %	30%	13%	6%	-18%	8%	29%	26%	27%
Other Income	32	204	170	159	79	24	57	73
Interest	4	6	9	21	17	6	10	10
Depreciation	35	22	35	47	50	49	55	57
Profit before tax	238	210	148	48	38	105	148	192
Tax %	19%	12%	5%	-18%	29%	36%	10%	—
Net Profit	194	184	141	57	27	68	133	183
EPS in Rs	11.88	11.31	8.12	3.29	1.55	3.47	6.80	9.34
Dividend Payout %	5%	5%	7%	0%	0%	14%	9%	—

SHILPAMED balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	9	9	9	10	20
Reserves	1,273	1,445	1,630	2,057	2,109	2,134	2,637	2,694
Borrowings	186	380	655	195	290	144	98	132
Other Liabilities	201	188	225	635	112	132	193	183
Total Liabilities	1,668	2,021	2,517	2,896	2,519	2,419	2,938	3,029
Fixed Assets	511	517	641	566	609	586	570	639
CWIP	401	373	482	293	226	228	278	297
Investments	89	93	219	238	244	246	1,236	1,223
Other Assets	667	1,038	1,175	1,800	1,439	1,358	854	870
Total Assets	1,668	2,021	2,517	2,896	2,519	2,419	2,938	3,029

SHILPAMED cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	164	130	70	174	2	10	-19	60
Cash from Investing Activity	-215	-295	-238	-379	-95	155	-431	-68
Cash from Financing Activity	8	170	256	97	88	-163	450	14
Net Cash Flow	-42	5	87	-108	-5	2	0	6
Free Cash Flow	-108	-204	-196	0	-56	-46	-76	-67
CFO/OP	113%	70%	336%	954%	-24%	64%	-1%	52%

SHILPAMED shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	44.23%	44.23%	44.23%	44.23%	40.13%	40.13%	40.13%	40.13%
FIIs	9.90%	10.97%	11.19%	10.92%	10.97%	11.07%	11.39%	12.11%
DIIs	8.27%	7.55%	7.46%	7.67%	8.34%	8.58%	8.05%	8.26%
Public	37.59%	37.25%	37.10%	37.18%	40.56%	40.21%	40.42%	39.49%
No. of Shareholders	49,034	50,108	48,636	52,065	53,799	53,410	60,926	87,477

SHILPAMED key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	100	103	310	105	165	170	136	136
Inventory Days	275	283	1,847	472	420	458	450	285
Days Payable	111	105	351	111	142	215	121	138
Cash Conversion Cycle	264	281	1,806	466	443	412	464	283
Working Capital Days	110	235	271	135	573	188	172	146
ROCE %	11%	15%	2%	1%	-1%	3%	6%	5%

SHILPAMEDUpdated 13 Oct 2026, 6:04

Shilpa Medicare Ltd

SHILPAMEDUpdated 13 Oct 2026, 6:04

Market Cap

₹19,830Cr.

Current Price

₹1,014

High / Low

₹1,096/260

Stock P/E

127

ROE3.88%

ROCE4.79%

Book Value₹139

Face Value₹1.00

Dividend Yield0.06%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	38	7	68	14	12	-35	8	-38	-2.19
Sep 2023	75	5	67	23	13	12	45	7	0.38
Dec 2023	64	3	67	22	12	4	31	3	0.16
Mar 2024	59	3	80	19	12	-17	10	-18	-1.06
Jun 2024	96	2	73	31	12	40	31	28	1.43
Sep 2024	130	1	87	20	12	50	40	30	1.53
Dec 2024	125	1	103	16	12	25	37	16	0.8
Mar 2025	126	2	88	-34	12	-10	-43	-6	-0.29
Jun 2025	92	2	75	13	13	15	-40	21	1.06
Sep 2025	135	2	96	15	13	39	21	31	1.58
Dec 2025	166	3	135	9	14	24	33	16	0.81
Mar 2026	201	3	141	35	14	78	9	71	3.63
Jun 2026	189	3	133	13	15	51	-27	65	3.32

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	565	4	429	5	19	119	29	84	5.45
Mar 2016	676	3	511	9	21	149	24	113	7.32
Mar 2017	734	3	551	15	27	169	24	127	7.95
Mar 2018	741	2	562	23	33	167	20	133	8.17
Mar 2019	664	3	487	21	34	162	23	124	7.61
Mar 2020	806	4	561	32	35	238	19	194	11.88
Mar 2021	257	6	223	204	22	210	12	184	11.31
Mar 2022	357	9	335	170	35	148	5	141	8.12
Mar 2023	248	21	291	159	47	48	-18	57	3.29
Mar 2024	310	17	284	79	50	38	29	27	1.55
Mar 2025	476	6	340	24	49	105	36	68	3.47
Mar 2026	596	10	440	57	55	148	10	133	6.8
TTM	691	10	505	73	57	192	—	183	9.34

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	40.13%
FIIs	12.11%
DIIs	8.26%
Public	39.49%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	50.01%	8.52%	0.06%	41.41%
Mar 2024	50.01%	5.63%	1.65%	42.71%
Jun 2024	44.39%	9.08%	7.61%	38.91%
Sep 2024	44.33%	9.59%	8.18%	37.9%
Dec 2024	44.23%	9.9%	8.27%	37.59%
Mar 2025	44.23%	10.97%	7.55%	37.25%
Jun 2025	44.23%	11.19%	7.46%	37.1%
Sep 2025	44.23%	10.92%	7.67%	37.18%
Dec 2025	40.13%	10.97%	8.34%	40.56%
Mar 2026	40.13%	11.07%	8.58%	40.21%
Jun 2026	40.13%	11.39%	8.05%	40.42%
Sep 2026	40.13%	12.11%	8.26%	39.49%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	555	87	132	783	280	88	140	275	783
Mar 2016	8	657	86	178	929	350	89	154	336	929
Mar 2017	8	1022	237	224	1490	449	137	326	579	1490
Mar 2018	8	1149	186	204	1547	489	201	231	627	1547
Mar 2019	8	1273	186	201	1668	511	401	89	667	1668
Mar 2020	8	1445	380	188	2021	517	373	93	1038	2021
Mar 2021	8	1630	655	225	2517	641	482	219	1175	2517
Mar 2022	9	2057	195	635	2896	566	293	238	1800	2896
Mar 2023	9	2109	290	112	2519	609	226	244	1439	2519
Mar 2024	9	2134	144	132	2419	586	228	246	1358	2419
Mar 2025	10	2637	98	193	2938	570	278	1236	854	2938
Mar 2026	20	2694	132	183	3029	639	297	1223	870	3029

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	67	-139	74	2
Mar 2016	120	-101	-15	4
Mar 2017	50	-275	315	91
Mar 2018	54	-13	-61	-20
Mar 2019	164	-215	8	-42
Mar 2020	130	-295	170	5
Mar 2021	70	-238	256	87
Mar 2022	174	-379	97	-108
Mar 2023	2	-95	88	-5
Mar 2024	10	155	-163	2
Mar 2025	-19	-431	450	0
Mar 2026	60	-68	14	6

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	45	60	83	107	100	103	310	105	165	170	136	136
Inventory Days	142	126	173	174	275	283	1,847	472	420	458	450	285
Days Payable	77	99	103	103	111	105	351	111	142	215	121	138
Cash Conversion Cycle	110	87	153	179	264	281	1,806	466	443	412	464	283
Working Capital Days	37	33	83	103	110	235	271	135	573	188	172	146
ROCE %	21%	21%	16%	12%	11%	15%	2%	1%	-1%	3%	6%	5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SHILPA MEDICARE LTD (SHILPAMED)?

The reported market capitalisation for SHILPA MEDICARE LTD (SHILPAMED) is ₹19,830Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SHILPAMED?

The current price shown for SHILPA MEDICARE LTD (SHILPAMED) on Fincrux is ₹1,014 with a 52-week high/low of ₹1,096/260.

What is the P/E ratio of SHILPA MEDICARE LTD (SHILPAMED)?

The stock P/E for SHILPA MEDICARE LTD (SHILPAMED) is 127 on Fincrux, with ROE at 3.88% and ROCE at 4.79%.

What were SHILPAMED latest quarterly results?

For Jun 2026, SHILPA MEDICARE LTD (SHILPAMED) reported sales ₹189 Cr and net profit ₹65 Cr (figures in ₹ crore unless noted).

What are SHILPAMED annual sales and net profit?

For TTM, SHILPA MEDICARE LTD (SHILPAMED) shows sales of ₹691 Cr and net profit of ₹183 Cr on the Fincrux profit & loss statement.

Who owns SHILPA MEDICARE LTD (SHILPAMED)?

Latest shareholding for SHILPA MEDICARE LTD (SHILPAMED) on Fincrux: Promoters 40.13% (Sep 2026), FIIs 12.11% (Sep 2026), DIIs 8.26% (Sep 2026), Public 39.49% (Sep 2026), No. of Shareholders 87,477% (Sep 2026).

Where can I find SHILPA MEDICARE LTD (SHILPAMED) financials?

SHILPA MEDICARE LTD (SHILPAMED) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SHILPAMED balance sheet and cash flow?

Yes. The SHILPA MEDICARE LTD (SHILPAMED) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 6:04